Marisa Calabuig Muñoz

6PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesCardiovascular medicine and haematology not elsewhere classifiedInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|Aug 14, 2025
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Laura Torres-Miñana, Blanca Boluda, Antonio Solana-Altabella

|Feb 22, 2023
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.

Christelle Ferra Coll, Mireia Morgades de la Fe, Laura Prieto García

|Jan 04, 2023
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.

José Luis Piñana, Lourdes Vazquez, Marisa Calabuig

|Nov 11, 2017
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.

Mar Tormo, Ariadna Pérez-Martínez, Marisa Calabuig

Pageof 1

Frequent Collaborators

2 joint publications

Mar Tormo

2 joint publications

José Luis Piñana

2 joint publications

Mireia Morgades de la Fe

2 joint publications

Rodrigo Martino Bofarull